Japan’s Takeda to acquire the US’ Maverick Therapeutics

Japan-based Takeda Pharmaceutical Company Limited has entered into an agreement to acquire private biopharmaceutical company Maverick Therapeutics, Inc. in a bid to expand its novel immuno-oncology portfolio. Credit: National Cancer Institute/Unsplash